Search - tctmd.com

Displaying 501 - 520 of 579

Sort: Relevancy | Date

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

Presentation TCT 2014

I-LOVE-IT 2: A Prospective, Randomized Trial of a Biodegradable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent Versus a Durable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Bo Xu

September 16, 2014

Presentation TCT 2014

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

TCT 346: Relationship Between Peripheral Artery Disease and Coronary Plaque Morphology: An ADAPT-DES Intravascular Ultrasound Substudy

Presenter: Charles J. Davidson, Robert J. Russo, Ryan D. Madder, Mitsuaki Matsumura

September 15, 2014

Presentation TCT 2014

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Rui Campante Teles

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

Presentation TCT 2014

Coronary Artery Disease and TAVR: Who, When, and How to Revascularize?

Presenter: Sarah Clarke, Marian C. Hawkey, Thomas H. Maloney, Jeffrey J. Popma

September 14, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

Presentation TCT 2014

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Jae-Sik Jang, MD

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

ISAR-CLOSURE: Vascular Closure Devices Noninferior to Manual Compression in Transfemoral Angiography

September 13, 2014

Presentation TCT 2014

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh

September 12, 2014

News Conference News TCT 2013

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

November 07, 2013

Presentation TCT 2013

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

News Conference News TCT 2013

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

October 31, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with Minimal Symptoms but Multivessel Coronary Artery Disease and Depressed left Ventricular Function

Presenter: Divaka Perera

October 30, 2013

Advertisement

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

I-LOVE-IT 2: A Prospective, Randomized Trial of a Biodegradable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent Versus a Durable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

TCT 346: Relationship Between Peripheral Artery Disease and Coronary Plaque Morphology: An ADAPT-DES Intravascular Ultrasound Substudy

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

Keynote Address Focuses on Newer DES, Problematic Subgroups

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Coronary Artery Disease and TAVR: Who, When, and How to Revascularize?

PCI for CTO Ups Survival vs. Medical Therapy, CABG

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

ISAR-CLOSURE: Vascular Closure Devices Noninferior to Manual Compression in Transfemoral Angiography

Coronary Artery Disease: Pathology and Pathogenesis

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

Case Presentation Introduction: A Patient with Minimal Symptoms but Multivessel Coronary Artery Disease and Depressed left Ventricular Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content